Categories: News

Vistin Pharma ASA: Key information relating to the proposed cash dividend

The Board of Directors of Vistin Pharma ASA (VISTN) will propose to distribute a cash dividend of total NOK 1.25 per share, to be paid in June, for the accounting year of 2024. The formal decision regarding the dividend will be made on the company’s Annual General Meeting, which will be held on 22 May 2025.

Dividend amount (per share): NOK 1.25

Declared currency: NOK

Last day including right: 3 June 2025

Ex-date: 4 June 2025

Record date: 5 June 2025

Payment date (on or about): 12 June 2025

Date of approval: 22 May 2025

For further information, please contact:

Alexander Karlsen

CFO

+47 97 05 36 21

alexander.karlsen@vistin.com

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

13 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

15 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

15 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

15 hours ago